CLDN5 and diabetes mellitus: BHB inhibits HDAC3 and leads to acetylation of H3K14 in the Claudin-5 promoter, thereby promoting Claudin-5 production and antagonizing diabetes-related cardiac microvascular hyperpermeability (28).